French Heiress Behind Botox Rival Quits UK as Succession Looms

Anne Beaufour, heiress to pharmaceutical firm Ipsen, has changed her residency from the UK to Switzerland amid a generational succession plan involving the transfer of shares to her children. The Beaufour siblings have structured their €4.5bn wealth through offshore holdings, with Anne’s move reflecting broader tax-motivated shifts among Europe’s ultra-rich. According to Philippe Pelé-Clamour interviewed by Bloomberg, adjunct professor at HEC Paris Business School, their strategy is clearly designed to protect both personal assets and the company, and signals a well-advanced transition plan.